Myosana Therapeutics, Inc. — Form C/A (Regulation Crowdfunding)
Myosana Therapeutics, Inc. of Seattle, WA filed a Form C/A (Regulation Crowdfunding) with the SEC on 2026-04-28. Target raise $50K, up to $1.2M. Offered through Wefunder Portal LLC.
Offering
- Filed: 2026-04-28
- Form: C/A
- Accession: 0001955277-26-000001
- Target amount: $50K
- Maximum amount: $1.2M
- Security type: Other
- Securities offered: 50,000
- Price: $1.0000
- Deadline: 2027-04-30
- Funding portal / intermediary: Wefunder Portal LLC
- Intermediary file number: 007-00033
- Intermediary CRD: 283503
Issuer
- CIK: 0001955277
- Website: https://myosanatherapeutics.com
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2018-07-17
- Address: 8502 30th Avenue Northwest, Seattle, WA, 98117
- Employees: 0
Financials (as filed)
- Total assets (most recent): $945K
- Cash (most recent): $37K
- Net income (most recent): $-1.2M
- Net income (prior): $-1.6M
- Short-term debt: $9K
People (3)
| Name | Role | Location |
|---|
| Stanley Froehner | CFO, Chairman and Co-Founder | Seattle, WA |
| Matthew Lumley | Board Director | Seattle, WA |
| Nicholas Whitehead | CEO, Co-Founder and CSO | Seattle, WA |
Reg CF filing history (2)
More